Protein Science
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print September 30, 2004
Protein Science, DOI: 10.1110/ps.04847404
Copyright © 2004 The Protein Society
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ps.04847404v1
13/11/2888    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, J. R.
Right arrow Articles by Murphy, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, J. R.
Right arrow Articles by Murphy, R. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Urea modulation of {beta}-amyloid fibril growth: Experimental studies and kinetic models

Jin Ryoun Kim1,4, Adrian Muresan2, Ka Yee C. Lee3 and Regina M. Murphy1

1 Department of Chemical and Biological Engineering, University of Wisconsin, Madison, Wisconsin 53706, USA
2 Department of Physics and 3 Department of Chemistry, Institute for Biophysical Dynamics, and the James Franck Institute, University of Chicago, Chicago, Illinois 60637, USA

(RECEIVED May 3, 2004; FINAL REVISION July 21, 2004; ACCEPTED July 22, 2004)

Aggregation of {beta}-amyloid (A{beta}) into fibrillar deposits is widely believed to initiate a cascade of adverse biological responses associated with Alzheimer’s disease. Although it was once assumed that the mature fibril was the toxic form of A{beta}, recent evidence supports the hypothesis that A{beta} oligomers, intermediates in the fibrillogenic pathway, are the dominant toxic species. In this work we used urea to reduce the driving force for A{beta} aggregation, in an effort to isolate stable intermediate species. The effect of urea on secondary structure, size distribution, aggregation kinetics, and aggregate morphology was examined. With increasing urea concentration, {beta}-sheet content and the fraction of aggregated peptide decreased, the average size of aggregates was reduced, and the morphology of aggregates changed from linear to a globular/linear mixture and then to globular. The data were analyzed using a previously published model of A{beta} aggregation kinetics. The model and data were consistent with the hypothesis that the globular aggregates were intermediates in the amyloidogenesis pathway rather than alternatively aggregated species. Increasing the urea concentration from 0.4 M to 2 M decreased the rate of filament initiation the most; between 2 M and 4 M urea the largest change was in partitioning between the nonamyloid and amyloid pathways, and between 4 M and 6 M urea, the most significant change was a reduction in the rate of filament elongation.

Keywords: amyloid; {beta}-amyloid; light scattering; atomic force microscopy; peptide aggregation

Abbreviations: A{beta}, {beta}-amyloid • AFM, atomic force microscopy • CD, circular dichroism • DLS, dynamic light scattering • PrP, prion protein • SEC, size exclusion chromatography.

Article published online ahead of print. Article and publication date are at http://www.proteinscience.org/cgi/doi/10.1110/ps.04847404.


Reprint requests to: Regina M. Murphy, Department of Chemical and Biological Engineering, University of Wisconsin, 1415 Engineering Drive, Madison, WI 53706, USA; e-mail: murphy{at}che.wisc.edu; fax: (608) 262-5434.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Protein Sci.Home page
S. Lee, E. J. Fernandez, and T. A. Good
Role of aggregation conditions in structure, stability, and toxicity of intermediates in the Abeta fibril formation pathway
Protein Sci., April 1, 2007; 16(4): 723 - 732.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. A. Vitrenko, E. O. Gracheva, J. E. Richmond, and S. W. Liebman
Visualization of Aggregation of the Rnq1 Prion Domain and Cross-seeding Interactions with Sup35NM
J. Biol. Chem., January 19, 2007; 282(3): 1779 - 1787.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-R. Chen and C. G. Glabe
Distinct Early Folding and Aggregation Properties of Alzheimer Amyloid-beta Peptides Abeta40 and Abeta42: STABLE TRIMER OR TETRAMER FORMATION BY Abeta42
J. Biol. Chem., August 25, 2006; 281(34): 24414 - 24422.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2004 by The Protein Society.